We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$59.5B
AUM Growth
+$3.71B
Cap. Flow
+$2.71B
Cap. Flow %
4.55%
Top 10 Hldgs %
19.97%
Holding
3,755
New
295
Increased
1,969
Reduced
1,191
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 10.24%
2 Financials 9.05%
3 Healthcare 7.82%
4 Industrials 6.6%
5 Energy 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOV icon
3376
Hovnanian Enterprises
HOV
$807M
$101K ﹤0.01%
2,468
WTI icon
3377
W&T Offshore
WTI
$518M
$101K ﹤0.01%
+14,147
New +$91.4K
JHY
3378
DELISTED
Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest
JHY
$101K ﹤0.01%
10,072
TTOO
3379
DELISTED
T2 Biosystems, Inc
TTOO
$100K ﹤0.01%
+3
New +$114K
BP icon
3380
CALL
BP
BP
$107B
$99K ﹤0.01%
+97,747
New +$4.11M
GORO icon
3381
Goldgroup Mining Inc.
GORO
$191M
$99K ﹤0.01%
+15,002
New +$84.3K
ACTG icon
3382
Acacia Research
ACTG
$470M
$98K ﹤0.01%
23,640
-1,500
-6% -$5.76K
UAN icon
3383
CVR Partners
UAN
$1.34B
$97K ﹤0.01%
2,948
ASNA
3384
DELISTED
Ascena Retail Group, Inc.
ASNA
$97K ﹤0.01%
1,213
+175
+17% +$10.6K
ADMA icon
3385
ADMA Biologics
ADMA
$2.22B
$96K ﹤0.01%
+21,320
New +$106K
IMUX icon
3386
Immunic
IMUX
$195M
$96K ﹤0.01%
35
-57
-62% -$132K
CRBP icon
3387
Corbus Pharmaceuticals
CRBP
$190M
$94K ﹤0.01%
620
+90
+17% +$16.4K
JOB icon
3388
GEE Group
JOB
$22.5M
$94K ﹤0.01%
40,853
IID
3389
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$94K ﹤0.01%
14,148
-3,000
-17% -$20.6K
DS
3390
DELISTED
Drive Shack Inc.
DS
$92K ﹤0.01%
+11,875
New +$71.6K
CRD.A icon
3391
Crawford & Co Class A
CRD.A
$669M
$90K ﹤0.01%
10,426
-391
-4% -$3.14K
CSFL
3392
PUT
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$90K ﹤0.01%
+60,000
New +$1.78M
TLGT
3393
DELISTED
Teligent, Inc
TLGT
$88K ﹤0.01%
2,530
-460
-15% -$14.5K
LITE icon
3394
CALL
Lumentum
LITE
$69.3B
$87K ﹤0.01%
32,100
-900
-3% -$53.6K
NSL
3395
DELISTED
NUVEEN SENIOR INCM FD
NSL
$86K ﹤0.01%
+13,736
New +$89.2K
BX icon
3396
CALL
Blackstone
BX
$110B
$85K ﹤0.01%
50,000
-74,100
-60% -$2.36M
UUU icon
3397
Universal Safety Products Inc
UUU
$10.6M
$85K ﹤0.01%
73,513
RRD
3398
DELISTED
RR Donnelley & Sons Co.
RRD
$82K ﹤0.01%
14,248
+96
+0.7% +$708
VOC icon
3399
VOC Energy
VOC
$51.9M
$77K ﹤0.01%
14,548
-5,000
-26% -$25.2K
TEUM
3400
DELISTED
Pareteum Corporation
TEUM
$77K ﹤0.01%
30,932
-1,000
-3% -$2.5K

Similar funds

Raymond James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Raymond James & Associates held 3,755 positions worth $59.5B, up 6.7% from $55.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.71B of net new capital in Q2 2018, opening 295 new positions and adding to 1,969 existing holdings. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $97.9M trimmed.

  • Raymond James & Associates's largest Q2 2018 buy was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.
  • Raymond James & Associates added most to iShares Core MSCI EAFE ETF in Q2 2018, an estimated $167M increase.
  • Raymond James & Associates's biggest Q2 2018 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $97.9M.
  • Raymond James & Associates fully exited Time Warner Inc in Q2 2018, selling an estimated $118M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $59.5B portfolio in Q2 2018.
  • Raymond James & Associates opened 295 new positions and closed 173 in Q2 2018.
  • Raymond James & Associates's portfolio value rose 6.7% quarter-over-quarter to $59.5B.

Based on Raymond James & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.